Back
Enanta Pharmaceuticals Stock Predictions
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
24
ENTA
Enanta Pharmaceuticals
Last Price:
$5.27
Seasonality Move:
-1.62%
7 Day Trial
ALL ACCESS PASS
$
7
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report hereEnanta Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Enanta Pharmaceuticals has on average historically risen by 8.2% based on the past 12 years of stock performance.
-
Enanta Pharmaceuticals has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Enanta Pharmaceuticals Stock Undervalued?The current Enanta Pharmaceuticals [ENTA] share price is $5.27. The Score for ENTA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
ENTA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Enanta Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Enanta Pharmaceuticals has on average historically risen by 8.2% based on the past 12 years of stock performance.
Enanta Pharmaceuticals Stock Rating
Sell
24
Enanta Pharmaceuticals (ENTA)
is a Sell
Is Enanta Pharmaceuticals overpriced?
-
Enanta Pharmaceuticals has risen higher in 4 of those 12 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Enanta Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
enanta.com
52-Week Data
52-Week High:
17.24
52-Week Low:
4.09
Prediction Charts
Market Cap:
112.4M
Price in USD:
5.27
Volume:
81.5K
Beta:
0.64
Technical Analysis
SMA50:
5.85
SMA100:
5.88
SMA200:
8.75
52-Wk Change:
-59.24%
Stock Predictions
-
Is Enanta Pharmaceuticals stock public?Yes, Enanta Pharmaceuticals is a publicly traded company.
-
What is the Enanta Pharmaceuticals stock quote today?The Enanta Pharmaceuticals stock price is 5.27 USD today.
-
How to buy Enanta Pharmaceuticals stock online?You can buy Enanta Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-22 | 5.30 | 5.50 | 5.55 | 5.20 |
| Apr-23 | 5.59 | 5.60 | 5.75 | 5.47 |
| Apr-24 | 5.59 | 5.67 | 5.68 | 5.33 |
| Apr-25 | 5.61 | 5.58 | 5.70 | 5.39 |
| Apr-28 | 5.56 | 5.63 | 5.80 | 5.56 |
| Apr-29 | 5.63 | 5.79 | 5.82 | 5.53 |
| Apr-30 | 5.71 | 6.09 | 6.17 | 5.65 |
| May-1 | 5.86 | 6.05 | 6.23 | 5.86 |
| May-2 | 6.12 | 5.95 | 6.15 | 5.94 |
| May-5 | 5.87 | 5.44 | 5.87 | 5.44 |
| May-6 | 5.31 | 5.05 | 5.52 | 5.04 |
| May-7 | 5.04 | 5.06 | 5.15 | 4.99 |
| May-8 | 5.08 | 5.32 | 5.34 | 4.96 |
| May-9 | 5.31 | 5.27 | 5.52 | 5.25 |
Enanta Pharmaceuticals Earnings
Enanta Pharmaceuticals Earnings Report: Per Share Enanta Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Enanta Pharmaceuticals Forecast Revenue Growth
Enanta Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Enanta Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $0.11 per share.
* Enanta Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.